Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
Lorundrostat Stands a Chance Against Obesity-Related Hypertension Selective aldosterone synthase inhibitor proceeds to phase III study after Target-HTN's success Sep 10, 2023
Optimal BP After Stroke; Psilocybin for Depression Also in TTHealthWatch: culprit vessel or complete revascularization? Sep 09, 2023 podcast
Calcium Channel Blockers Again Linked to Glaucoma But researcher says there's no need to switch most users to other antihypertensive drugs Sep 07, 2023
Predicting ICU Outcomes; Post-Stroke Brain Stimulation Also in TTHealthWatch: effect of frailty on intensive blood pressure control Sep 02, 2023 podcast
Medtronic's Renal Denervation System for Hypertension Splits FDA Panel Once resurrected, is radiofrequency renal denervation heading back to limbo? Aug 24, 2023
FDA Panel Backs ReCor's Renal Denervation System for Hypertension Device-based treatment passes hurdle despite concerns about effectiveness Aug 22, 2023
FDA Advisors' Recommendation on Renal Denervation Hinges on Effectiveness Question Device-based hypertension treatments have only modest BP reductions Aug 21, 2023
'Exciting' siRNA Therapy for Hypertension Passes First Hurdle Injections stop liver-specific synthesis of angiotensinogen Jul 19, 2023
Early-Pregnancy Serial BP Measurements Can Reclassify Risk of Preeclampsia BP trajectories improve on prediction using standard risk factors alone Jul 13, 2023
New Evidence Links Calcium Channel Blockers to Increased Risk of Glaucoma Meta-analysis shows highest glaucoma risk with CCB monotherapy, reduced IOP with beta-blockers Jun 13, 2023
Extreme Morning Sickness Factors Into Subsequent Cardiovascular Risk for Moms Novel risk factor did not hinge on preeclampsia Jun 02, 2023
Genetic Risk Score Predicts Hypertensive Disorders of Pregnancy Over a dozen genetic loci linked to preeclampsia, gestational hypertension Jun 01, 2023
Lower BP Might Mean Less Cardiac Conduction Disease SPRINT post hoc analysis suggests a means for prevention May 03, 2023
Nonimmunosuppressive Therapy Bests ARB for Cutting Proteinuira in IgA Nephropathy Interim PROTECT data show nephroprotective potential of sparsentan Apr 15, 2023
Fresh Produce Is an Increasingly Popular Prescription for Chronically Ill Patients But do these initiatives work? Mar 26, 2023
Sotatercept, Fixed-Dose Combo Therapy on the Right Path for PAH More therapeutic options suggested by STELLAR, A DUE trials Mar 06, 2023
A New Framework for Treating Hypertension Harlan Krumholz, MD, on breaking down the barriers to blood pressure control Mar 06, 2023 video
Novel Antihypertensive Stumbles Over Early-Phase Hurdle Hopes remain high for baxdrostat despite trial's adherence problems Mar 05, 2023
Daily Thiazide No Help in Preventing Recurrent Kidney Stones Three different dosages of hydrochlorothiazide no better than placebo Mar 01, 2023
Calcium Channel Blocker Preserves Some Beta Cell Function in Early T1D But intensive glucose control didn't preserve pancreatic C-peptide secretion Feb 24, 2023
Does COVID Vaccine Blunt Elevated Diabetes Risk After Infection? Unvaccinated had a 78% higher risk for new-onset diabetes; no link seen among the vaccinated Feb 14, 2023
CATIS-2: Delayed Antihypertension Tx for Acute Ischemic Stroke Still an Option Early therapy not a better bet for cutting death and disability risks at 3 months Feb 11, 2023
BEST-II Throws Cold Water on Already-Tepid BP Lowering After Stroke Thrombectomy Trial did not show definite harm, but benefit is unlikely Feb 10, 2023
No Blaming Common Antihypertensives for Pancreatic Cancer, Study Suggests Some reassurance on widely prescribed dihydropyridine calcium channel blockers Dec 15, 2022
Should We Change Target Blood Pressure? Harlan Krumholz, MD, reviews cardiovascular studies and proposes ways to rethink patient outcomes Dec 07, 2022 video
Combo Treatment Could Delay Kidney Failure for Years in Nondiabetic CKD Big benefits projected with SGLT2/RAAS inhibitor combination therapy Nov 23, 2022
Strong Showing for Novel BP-Lowering Drugs in Resistant Hypertension Aprocitentan targets the endothelin pathway, whereas baxdrostat blocks aldosterone production Nov 09, 2022
Diuretics on Par in Head-to-Head Comparison for Hypertension But a surprise signal emerges for one group in pragmatic trial Nov 06, 2022
Not So Cool After All: No CV Benefit With Lower-Temp Dialysate in Hemodialysis Some patients in MyTEMP trial even complained cooler dialysate was "worst possible feeling" Nov 06, 2022
Stop RAS Inhibitors in Advanced CKD? STOP ACEi Trial Sheds Some Light Findings do not support discontinuation to improve kidney function, researchers say Nov 03, 2022
RDN Powers Through Another Off-Med Trial, Clinical Benefits Still Untested Plus, an apparent magnification of effect in SYMPLICITY HTN-3 Sep 19, 2022
Make the Diagnosis: Increased Hair Loss and 'White Bulbs' -- What’s Up? A 55-year-old woman visited her doctor after noticing that the hair on her scalp was falling out at an increased rate over the last 3 months. Sep 14, 2022
Some Reassurance That a Cuffless BP Sensor Works Regardless of Body Fat, Skin Color Study of the Biobeats sensor prompted by concerns from the FDA Sep 11, 2022
Does the Picture of HTN Disorders in Children Vary by Age, Preterm Birth? Preliminary findings from an epidemiological study of pediatric hypertension Sep 11, 2022
Do Some Â鶹´«Ã½ Need to Get Better at Documenting Hypertension in Patient Notes? Study finds settings where BP documentation is especially lax Sep 11, 2022
BP Lowering in Pregnant Women Continues to Take Shape Clinical guidance released, further studies planned in CHAP trial aftermath Sep 10, 2022
Pharmacist-Led Hypertension Clinics Able to Lower BP Within Weeks Broader implementation of programs hinges on state policies Sep 09, 2022
Self-Measured BP Struggles to Get Off the Ground During the Pandemic Lessons learned from the implementation of BP telemonitoring Sep 08, 2022
